07:00 , Sep 21, 1998 |  BC Week In Review  |  Company News

AMDL, Briana deal

The companies agreed in principle to end a 1995 joint venture (see BioCentury, Sept. 18, 1995). AMDD will regain worldwide marketing rights for its DR-70 immunoassay cancer screening kit. The kit is approved in Canada....
07:00 , Aug 3, 1998 |  BC Week In Review  |  Company News

BioChem, Briana, Qualia Computing Inc. deal

BCHE and BIA formed a partnership to develop and commercialize BIA's Second Look computerized mammogram analysis system to detect breast cancer, as well as other detection applications. BIA licensed the system from Qualia last year...
07:00 , Jun 22, 1998 |  BC Week In Review  |  Company News

BioChem, Briana deal

The companies signed a heads of agreement to develop and commercialize Second Look, a computerized breast cancer detection system that locates potentially cancerous regions on mammograms. BioChem Pharma Inc. (BCHE), Laval, Quebec   Briana Bio-Tech...
07:00 , May 18, 1998 |  BC Week In Review  |  Company News

Briana management update

Briana Bio-Tech Inc. (VSE:BIA), Montreal, Quebec   Business: Cancer, Neurological   Hired: Gaetan Carrier as CFO, formerly VP of finance and administration at AXA Assurances Inc.  ...
08:00 , Mar 30, 1998 |  BC Week In Review  |  Company News

Briana board of directors update

Briana Bio-Tech Inc. (VSE:BIA), Montreal, Quebec   Business: Cancer, Neurological   Appointed: Alan Smith, accountant and independent consultant  ...
08:00 , Mar 9, 1998 |  BC Week In Review  |  Company News

Briana board of directors update

Briana Bio-Tech Inc. (VSE:BIA), Montreal, Quebec   Business: Cancer, Neurological   Appointed: Gervais Dionne, EVP of R&D at BioChem Pharma Inc. , as chairman  ...
07:00 , Oct 13, 1997 |  BC Week In Review  |  Company News

Briana, University of Alberta deal

BIA received an exclusive license from the university to a synthetic peptide to treat chronic progressive multiple sclerosis. BIA paid the university a C$250,000 (US$182,500) licensing fee and C$660,000 (US$481,800) to fund one year of...
07:00 , May 19, 1997 |  BC Week In Review  |  Company News

Briana, University of Alberta deal

BIA licensed technology to treat chronic progressive multiple sclerosis (MS) from the university’s Multiple Sclerosis Research Clinic. BIA will fund research and clinical development, and will receive worldwide commercialization rights and an option to license...
07:00 , May 5, 1997 |  BC Week In Review  |  Company News

Briana, Qualia Computing Inc. deal

BIA acquired the exclusive worldwide license to market Qualia's Computer Assisted Diagnostic system for the analysis and interpretation of mammographic films. BIA said it will spend about $4 million over two years to fund software...
07:00 , Apr 14, 1997 |  BC Week In Review  |  Company News

Briana, University of Alberta deal

Briana acquired exclusive rights to technology involving stimulation of an anti-tumor immune response by the genes B7-2 and GMCSF (see Clinical Status, B11). Briana will fund research at the university and clinical trials for three...